Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics at ASM Microbe 2023

/PRNewswire/ - Microbion Corporation today announced that the company has been selected to present a poster highlighting the results from an E. coli CRISPR/Cas...

Related Keywords

Houston ,Texas ,United States ,Hall ,Fenali Parekh ,Jeff Millard ,Microbion Corporation ,Microbion Corp ,Cystic Fibrosis Foundation ,Pravibismane Impacts Bacterial Bioenergetics ,Fatty Acid Biosynthesis ,Board Location ,Exhibit Poster Hall ,Antimicrobial Agents ,New Small ,Non Beta Lactamase Inhibitors ,Chief Scientific Officer ,Orphan Drug ,Fast Track ,